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Abstract 
 The tumor microenvironment (TME) governs all aspects of cancer progression and in vitro 
3D cell culture platforms are increasingly developed to emulate the interactions between 
components of the stromal tissues and cancer cells. However, conventional cell culture 
platforms are inadequate in recapitulating the TME, which has complex compositions and 
dynamically changing matrix mechanics. In this study, we developed a dynamic gelatin-
hyaluronic acid hybrid hydrogel system through integrating modular thiol-norbornene 
photopolymerization and enzyme-triggered on-demand matrix stiffening. In particular, gelatin 
was dually modified with norbornene and 4-hydroxyphenylacetic acid to render this bioactive 
protein photo-crosslinkable (through thiol-norbornene gelation) and responsive to tyrosinase-
triggered on-demand stiffening (through HPA dimerization). In addition to the modified gelatin 
that provides basic cell adhesive motifs and protease cleavable sequences, hyaluronic acid 
(HA), an essential tumor matrix, was modularly and covalently incorporated into the cell-laden 
gel network. We systematically characterized macromer modification, gel crosslinking, as well 
as enzyme-triggered stiffening and degradation. We also evaluated the influence of matrix 
composition and dynamic stiffening on pancreatic ductal adenocarcinoma (PDAC) cell fate in 
3D. We found that either HA-containing matrix or a dynamically stiffened microenvironment 
inhibited PDAC cell growth. Interestingly, these two factors synergistically induced cell 
phenotypic changes that resembled cell migration and/or invasion in 3D. Additional mRNA 
expression array analyses revealed changes unique to the presence of HA, to a stiffened 
microenvironment, or to the combination of both. Finally, we presented immunostaining and 
mRNA expression data to demonstrate that these irregular PDAC cell phenotypes were a result 
of matrix-induced epithelial-mesenchymal transition (EMT).  
Keywords: Pancreatic ductal adenocarcinoma, dynamic hydrogel, matrix stiffness, hyaluronic 
acid, epithelial-mesenchymal transition.  
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Introduction 
 Pancreatic cancer is currently the third leading cause of all cancer-related deaths. More 
than 53,000 new pancreatic cancer cases and 43,000 deaths are projected in 2017 [1]. The 
exceptionally dense stromal tissue (i.e., desmoplasia) in pancreatic ductal adenocarcinoma 
(PDAC), the most common form of pancreatic cancer, is considered the major hurdle to 
effective treatments [2]. Pancreatic desmoplasia is rich in extracellular matrix (ECM) proteins 
(e.g., collagen, fibronectin), glycosaminoglycans (GAGs, e.g., hyaluronic acid (HA)), cytokines 
(e.g., epidermal growth factor (EGF), transforming growth factor-β (TGF-β)), as well as immune 
and stromal cells [3-6]. The compositions in the stroma tissue act collectively to induce 
epithelial-mesenchymal transition (EMT) in cancer cells [7]. EMT is a complex process 
regulated by interactions of cancer-stromal cell, as well as bi-directional signaling between 
cancer cells and the surrounding tumor matrix [8, 9]. For example, inflammatory cytokines and 
growth factors, including TGF-β and EGF, are known to promote EMT in PDAC cells [9-12]. 
These cytokines are abnormally expressed during tumor progression, leading to downregulation 
of epithelial markers (e.g., E-Cadherin) and upregulation of mesenchymal markers (e.g., N-
Cadherin, SNAIL, TWIST, SLUG, ZEB1, etc.) [13, 14]. Under the stimulation of abnormally 
expressed cytokines, PDAC cells lose cell-cell junctions and transform into cells with a 
migratory and invasive phenotype. Moreover, these cellular changes render cancer cells 
chemo-resistant [7, 13, 15, 16]. 
 In addition to soluble cytokines, many ECM components are overexpressed by stromal and 
cancer cells during tumor progression. The accumulation of ECM proteins and GAGs around 
cancer cells builds up a dense desmoplasia that not only physically restricts penetration of 
chemotherapeutics but also causes abnormal mechanotransduction in cancer cells [17, 18]. For 
example, excessive accumulation of HA was detected in cell culture and in mature PDAC 
stroma [19]. HA binds to cell surface receptors, including CD44, layilin, and receptor for 
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hyaluronan-mediated motility (RHAMM) [19-21]. The activation of these receptors has been 
positively correlated with enhanced cancer cell proliferation, invasion, and drug resistance [22]. 
In addition, HA accumulation also leads to elevated fluid stress that could induce abnormal 
mechanosensing in the cancer cells and limit the transport of anti-cancer drugs [23, 24]. 
Nonetheless, the roles of HA in a stiffening microenvironment on PDAC cell EMT have not been 
extensively studied owing to the lack of an appropriate three-dimensional (3D) culture system 
capable of mimicking the dynamic stroma stiffening process.  
 To investigate cancer cell responses induced by ECM, most studies utilized two-
dimensional (2D) tissue culture plate coated with matrix proteins or 3D hydrogels with static or 
degrading mechanical property [25]. Unfortunately, these convenient culture platforms do not 
capture the dynamic landscape of a stiffening tumor microenvironment (TME). Some dynamic 
hydrogels have been developed to mimic the temporal mechanical changes of tumor matrix. For 
example, Suggs and colleagues developed an alginate-based hydrogel that could be 
dynamically stiffened by temperature-induced calcium release [26]. MCF10A mammary 
epithelial cells, which are non-tumorigenic, were nonetheless found to exhibit an invasive 
phenotype when cultured in a stiffened matrix, a result consistent with earlier work [27, 28]. In 
another example, Xu et al. developed a double-network dynamic hydrogel via a two-step light-
mediated polymerization process [29]. Methacrylate and cysteine dually functionalized HA was 
crosslinked into hydrogels through ultraviolet (UV) light polymerization, followed by infiltrating 
the hydrogel with additional macromers, photoinitiators, and secondary UV light-mediated 
polymerization. The authors concluded that encapsulated cancer cells became invasive in the 
stiffened gel. Although these strategies presented dynamic matrix stiffening, the components 
and approaches were either not biologically relevant to the TME due to the inclusion of alginate, 
or exposed cells to UV light excessively.  
 Our group has reported several semi-synthetic poly(ethylene glycol) (PEG)-peptide 
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hydrogels for in vitro culture of pancreatic cancer cells [10, 30-32]. For example, we have 
evaluated PDAC cell EMT in hydrogels immobilized with fibronectin or laminin-derived peptides 
[31]. We have also studied the influence of matrix-entrapped collagen-1 and soluble cytokines 
(e.g., TGF-β1 and EGF) on PDAC cell fate, including proliferation, chemo-resistance, and EMT 
in 3D [30]. In order to mimic the dynamic tumor stromal tissue, we have recently developed a 
tyrosinase-triggered post-gelation crosslinking platform for on-demand stiffening of cell-laden 
hydrogels [33]. These hydrogels were prepared by thiol-norbornene photopolymerization using 
8-arm PEG-norbornene (PEG8NB) and a simple peptide linker (i.e., KCYGPQGIWGQYCK) 
sensitive to both matrix metalloproteinase (MMP) induced cleavage and tyrosinase-triggered di-
tyrosine crosslinking. Following thiol-norbornene gelation, the tyrosine residues in the primary 
network served as substrates for exogenously added tyrosinase, which catalyzes di-tyrosine 
crosslinking and increases hydrogel crosslinking density and stiffness. Furthermore, enzyme-
triggered on-demand stiffened hydrogels altered morphology of pancreatic stellate cells (PSCs) 
cultured in 3D and resulted in upregulation of α-smooth muscle actin (αSMA), a signature 
marker of myofibroblastic activation.  
 Although the tyrosinase-stiffened PEG-peptide hydrogels have been useful in studying the 
effect of dynamic matrix stiffening on cancer stromal cell fate, these gels represented minimal 
tumor-related matrix components. In a separate study, our group designed biomimetic 
hydrogels formed by visible light initiated crosslinking of gelatin-norbornene (GelNB) and 
thiolated HA (THA) [32]. These gels were established to understand the effect of individual 
matrix component and static gel stiffness on PDAC cells grown in 3D but did not encompass 
dynamic stiffening feature. Here, we present a pathophysiologically relevant dynamic biomimetic 
hydrogel system where the gel network was formed by THA and dually-functionalized gelatin. 
The later was chemically modified with norbornene (NB) and hydroxyphenylacetic acid (HPA), 
yielding a multifunctional and cell responsive macromer (i.e., GelNB-HPA). Through orthogonal 
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thiol-norbornene photopolymerization, GelNB-HPA were modularly crosslinked by THA or by 
inert macromer PEG-tetra-thiol (PEG4SH). The bioactive peptide sequences on gelatin 
permitted cell adhesion and MMP-mediated local matrix cleavage. The conjugated HPA 
moieties rendered the cell-laden hydrogels sensitivity to tyrosinase-triggered di-HPA 
crosslinking, which led to physiologically relevant degree of on-demand stiffening in the 
presence of PDAC cells. With this new hybrid biomimetic hydrogel system, the effects of matrix 
biochemical and biophysical cues could be easily decoupled for gaining new insights into the 
effects of matrix compositions on PDAC cell behavior. We systematically characterized gel 
crosslinking and enzyme-triggered stiffening and degradation. We also studied the independent 
and synergistic effects of matrix compositions and dynamic stiffening on PDAC cell fate in 3D by 
analyzing cell morphological changes, immunostaining, and expression of PDAC-related genes 
at the mRNA level. Through modularly crosslinking and dynamically stiffening of tumor-mimetic 
matrices, we discovered the unique role of HA on PDAC cell fate processes and modulation of 
gene expression.    
Materials & Methods 
Materials 
 Gelatin type B, THA (MW: ~300 kDa), and PEG4SH (MW: 10 kDa) were obtained from 
Electron Microscopy Sciences, ESI Bio, and JenKem Technology USA, respectively. 
Collagenase-1 (300 U/mg) and hyaluronidase (770 U/mg) were purchased from Worthington 
Biochemical. All the other chemicals were obtained from Thermo Fisher unless noted otherwise. 
Synthesis of functionalized gelatin macromers 
 The synthesis of GelNB-HPA was achieved in two steps. First, gelatin-norbornene (GelNB) 
was synthesized by reacting gelatin with carbic anhydride as described previously [34]. The 
second functional group, HPA, was conjugated on the remaining amine groups on GelNB 
through standard carbodiimide chemistry with 1-ethyl-3-(3-dimethylaminopropyl)-carbodiimide 
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(EDC) and N-hydroxysuccinimide (NHS) as the coupling reagents [35]. The reaction was carried 
out for 24 hours and the degree of substitution was determined using fluoraldehyde assay with 
unmodified gelatin as the standards. The functionalization was also characterized by UV/Vis 
spectrophotometry (Synergy HT microplate reader, BioTek Instruments) and 1H NMR (Avance 
III 500, Brüker). 
Hydrogel fabrication and characterization  
 Hydrogels were prepared by reacting norbornene moieties of functionalized gelatin with 
thiol motifs on PEG4SH or THA via thiol-norbornene photopolymerization [36, 37]. Briefly, 
precursor solutions (45 µl/gel) composed of macromers and photoinitiator lithium 
acylphosphinate (LAP, 1 mM) were injected between two glass slides separated by 1-mm thick 
spacers. Gelation was achieved in 2 minutes under 365 nm light exposure (5 mW/cm2). 
Hydrogels were swollen in DPBS at 37ºC for 2 hours prior to characterization or stiffening 
experiments. Gelation kinetics and mechanical properties of hydrogels were characterized with 
a digital rheometer (Bohlin CVO100, Malvern Instruments). In situ gelation was performed in 
time-sweep mode using 10% strain, 1 Hz frequency, and a gap size of 90 µm. Hydrogel bulk 
moduli were obtained from averaging the linear region of the modulus-strain curves in strain-
sweep mode (8 mm parallel plate geometry with a gap size of 700 µm).  
Tyrosinase-triggered on-demand gel stiffening  
 Tyrosinase-triggered hydrogel stiffening was performed by incubating the pre-formed 
hydrogels in tyrosinase solution as described previously [33]. Afterwards, gels were transferred 
to DPBS (for cell-free gels) or fresh media (for cell-laden gels) in order to remove the residual 
tyrosinase trapped in the hydrogels.  
Enzymatic degradation of soft and stiffened hydrogels 
 Collagenase-1 and hyaluronidase were used to evaluate the susceptibility of the hydrogels 
to on-demand enzymatic degradation. Briefly, hydrogels were prepared with or without TYR-
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triggered stiffening as described in the section above. The gels were incubated in DPBS for one 
day prior to gravimetrically weighing to determine the initial gel mass (M0). Next, gels were 
incubated in respective enzyme solution for predefined periods of time and weighed to obtain 
current mass (Mt) and to determine percentage of mass loss (i.e., 100% x (M0 – Mt)/ M0). The 
degradation process was continued until the gels were completely degraded or no substantial 
changes in mass loss were observed. 
PDAC cell culture, encapsulation, and characterizations 
 COLO-357, a PDAC cell line with wild-type KRAS, was maintained in high glucose DMEM 
supplemented with 10% of fetal bovine serum (FBS, Gibco) and penicillin-streptomycin (Gibco, 
50 U/mL for both antibiotics). Cells were maintained in a standard cell culture incubator (37°C, 
5% CO2). Prior to encapsulation, cells were trypsinized and suspended in precursor solutions (to 
2×106 cells/mL) composed of photoinitiator LAP and required macromers (i.e., PEG4SH, THA, 
GelNB, or GelNB-HPA at desired concentrations as denoted in each Figure). Cell-precursor 
solution (25 µL) was loaded to a 1 mL disposable syringe with cut-open tip and exposed to 365 
nm light (5 mW/cm2) for 2 minutes. Cell-laden hydrogels were cultured in a 24-well plate. To 
evaluate cells viability, cell-laden gels were stained with live/dead staining kit (Life 
Technologies; Calcein-AM stained live cells green, Ethidium homodimer-1 stained dead cells 
red) and imaged via confocal microscopy (Olympus Fluoview FV100 laser scanning 
microscope). Z-stack images (100 µm thick, 10 µm per slice) were obtained from a minimum of 
three random areas within hydrogels. In addition, cells metabolic activity was obtained by using 
AlamarBlue assay (AbD Serotec; 10% in culture media, 2.5 hours of incubation time) and 
quantified via a microplate reader (Synergy HT, BioTek). Additional cell encapsulation studies 
were conducted using another human PDAC cell line, PANC-1, which harbors mutated KRAS. 
RNA Isolation, reverse transcription PCR, and real-time PCR 
 Samples of cell-laden hydrogels were collected in DNase/RNase-free microtubes, flash-
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frozen in liquid nitrogen and stored in −80°C. Tota l RNA was isolated from the encapsulated 
cells with NucleoSpin RNA II kit (Clontech). The concentration and purity of RNA were obtained 
by NanoDrop 2000 Spectrophotometer (Thermo Scientific). Next, purified RNA samples were 
converted into complementary DNA (cDNA) with PrimeScript RT Reagent Kit (Clontech, 
TaKaRa). For Taqman® array experiments, only samples with concentration greater than 100 
ng/mL, 260/280 > 2.0, 260/230 > 1.8 were used. cDNA samples were diluted to 100 ng/mL and 
mixed with same volume of Taqman® fast universal master mix. For 96 well TaqMan® Array 
Gene Signature Sets, 10 µl mixture was deposited in each well and detected by Applied 
Biosystems 7500 Fast Real-Time PCR machine. Three biological replicas were used for each 
experimental condition. Additional qPCR on EMT-related genes was performed using cDNA and 
SYBR Premix Ex TaqII kit (Clontech) with appropriate primers as listed in Table S1. The relative 
gene expression levels were analyzed by the 2-∆∆CT method with GAPDH as the internal control 
(i.e., housekeeping gene) and the expression level of respective gene in the control group (i.e., 
Gel/PEG gel with no HA and no stiffening) as the external control.  
Immunofluorescence staining and imaging 
 F-actin staining was used to visualize cytoskeletal structure of cells encapsulated in 3D 
environment with different matrix properties. Briefly, encapsulated cells were fixed in 4% 
paraformaldehyde for an hour at room temperature on an orbital shaker. Following fixation, 
samples were rinsed with DPBS and permeabilized with 1 mg/mL saponin at room temperature 
for 45 min. The samples were then washed with DPBS and blocked with 1% BSA and 10% FBS 
overnight at 4°C with shaking. The gels were then i ncubated overnight at 4°C in phalloidin 
solution (100 nM) and then washed with DPBS. Cell nuclei were counter-stained with DAPI 
(1:1000) for an hour at room temperature and rinsed three times with DPBS. Z-stack images (15 
µm thick, 1 µm per slice) were obtained with a confocal microscope. To examine potential EMT 
in the encapsulated cells, E-cadherin (E-cad) and N-cadherin (N-cad) were stained by 
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immunofluorescence. In brief, cell-laden gels were fixed, permeabilized, and blocked as 
described previously [38], followed by incubation with Rabbit anti-E-cad (1:100) and Mouse anti-
N-cad (1:100) at 4˚C for two days. After washing with DPBS extensively, samples were 
incubated with goat anti-Rabbit IgG (H+L)-Texas red or Alexa Fluor® 488-labeled goat anti-
mouse IgG F(ab’)2 for two days at 4˚C with gently shaking. Following by rinsing with DPBS and 
counter-staining with DAPI (1:1000), the samples were imaged by z-stack images (25 µm thick, 
1 µm per slice) confocal microscopy with appropriate filters.  
Statistical Analysis 
  All experiments were conducted independently three times with a minimum of three 
samples per condition. Numerical data were analyzed with two-way ANOVA on GraphPad 
Prism 7 software and reported as mean ± SEM. Single, double, and triple asterisks represent p 
< 0.05, 0.001, and 0.0001, respectively. p < 0.05 was considered statistically significant. For 
analyzing of Taqman® mRNA expression array, pairs of groups were compared with one-way 
ANOVA using Gel/PEG gels as the control (IBM SPSS software), following by Bonferroni post-
analysis (Table S2, S3).  
Results  
Principles of dynamic hydrogel design and macromer synthesis 
 In order to recapitulate the bioactive components and the stiffening tumor 
microenvironment in PDAC (Fig. 1A), we prepared gelatin-hyaluronic acid (Gel/HA) hydrogels 
capable of undergoing on-demand stiffening. We synthesized GelNB and GelNB-HPA (Fig. 1B), 
which could be modularly crosslinked with commercially available THA (Fig. 1C) through thiol-
norbornene photopolymerization. GelNB-HPA was synthesized through sequentially reacting 
gelatin with carbic anhydride (yielding GelNB) and 4-HPA (yielding GelNB-HPA). The degrees 
of gelatin functionalization, as characterized by fluoraldehyde assay, was ~37% and ~41% 
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respectively for NB and HPA modification (equivalent to 1.6 mM NB and 1.64 mM HPA per wt% 
gelatin, data not shown). The presence of NB group on gelation permitted rapid gelation with 
THA (within 2 minutes) through orthogonal thiol-norbornene photopolymerization (Fig. 1D). 
When GelNB-HPA was used, the gels could be dynamically stiffened due to tyrosinase-
triggered HPA dimerization (Fig. 1E). 
 Successful conjugation of NB and HPA moieties was characterized by 1HNMR (Fig. 2A). 
Chemical shifts between 6.1 – 6.3 ppm (blue region) indicated successful NB functionalization 
on the gelatin backbone (7.2 – 7.4 ppm, green region). After HPA conjugation, new chemical 
shifts emerged (6.9 – 7.2 ppm, red region) in GelNB-HPA, indicating the presence of aromatic 
HPA [39]. The modification of HPA on GelNB was further confirmed by UV/Vis absorbance 
spectrometry (Fig. 2B) through detecting increased absorbance at 280 nm [40]. UV/Vis 
spectrometry were also used to monitor tyrosinase-triggered HPA dimerization. Due to the 
limited amount of tyrosine residue in the unmodified gelatin sequence (<0.5%) [41], addition of 
tyrosinase (TYR, 1 kU/mL) did not change the absorbance signature of GelNB significantly (Fig. 
2C). However, when GelNB-HPA was treated with TYR, new absorbance shoulder emerged at 
~320 nm (Fig. 2D), suggesting that HPA motifs were dimerized by tyrosinase [42].    
Gel crosslinking and tyrosinase-mediated dynamic stiffening 
 To evaluate if conjugation of HPA on GelNB altered the efficiency of light-mediated thiol-
norbornene photopolymerization, we conducted in situ photorheometry using GelNB or GelNB-
HPA (7 wt%) and with PEG4SH (1.4 wt%) as the thiol crosslinker. As shown in Fig. 3A and 3B, 
gel points (i.e., storage modulus G’ surpassed loss modulus G”) were ~9 and ~18 seconds for 
gelation using GelNB and GelNB-HPA, respectively. However, G’ reached plateau within 2 
minutes for both gelatin macromers. Furthermore, gels prepared from GelNB-HPA had lower 
moduli (~1 kPa) compared with gels crosslinked by GelNB (~1.7 kPa). Hydrogels crosslinked by 
GelNB-HPA and PEG4SH were used to evaluate the efficiency of tyrosinase-triggered on-
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demand stiffening. As shown in Fig. 3C, gel moduli did not change overtime when the solution 
contained no TYR. Gel moduli only increased slightly when incubating with low TYR 
concentration (0.1 kU/mL) for 4 hours. When TYR concentration was increased to above 0.5 
kU/mL, hydrogels were significantly stiffened after only two hours of incubation. The color of 
gels treated with higher TYR concentrations was darker (Fig. 3D), indicative of HPA dimer 
formation and higher degree of stiffening.  
 In addition to TYR concentration, HPA contents in the hydrogel could also be modularly 
adjusted to control the degree of stiffening. As shown in Fig. 4A, hydrogels formed with pure 
GelNB (i.e., 0% GelNB-HPA) were not susceptible to TYR-triggered stiffening. However, when 
the amount of GelNB-HPA was modularly increased to 50% (i.e., half GelNB, half GelNB-HPA) 
and 100% (i.e., pure GelNB-HPA), gel were stiffened from ~1 kPa to ~2.2 kPa and ~2.9 kPa, 
respectively. We further adjusted the weight percentages of GelNB-HPA (e.g., 3, 5, 7 wt%) and 
PEG4SH (e.g., 0.6, 1, 1.4 wt%) in the macromer precursor solution to obtain gels with varying 
HPA contents but similar initial shear moduli (~1 kPa. Fig. 4B). Following tyrosinase treatment, 
gels with higher HPA content (i.e., 11.2 mM in 7 wt% GelNB-HPA) were stiffened to a higher 
degree (~2.7 kPa, Fig. 4B). We also prepared gels with different thiol/norbornene stoichiometric 
ratio (Rthiol/ene) but with the same HPA contents (i.e., 7 wt% GelNB-HPA and PEG4SH at 0.8, 
1.4, 2, or 2.8 wt%. Fig. 4C). There was a positive correlation between Rthiol/ene and initial gel 
modulus and these gels could all be dynamically stiffened regardless of the initial moduli (Fig. 
4C). Most importantly, once stiffened by TYR (1 kU/mL), all gels remained stiff for the next few 
days and the degree of stiffening (~1 kPa to ~8 kPa) was relevant to the stiffness change in a 
stiffening TME [43].   
Enzyme-mediated degradation of soft and stiffened hydrogels 
 Owing to the use of naturally derived macromers (i.e., gelation and HA), this hydrogel 
system was susceptible to degradation by cell-secreted collagenase and hyaluronidase. To 
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evaluate the degradability of these hydrogels, we crosslinked gels modularly using GelNB, 
GelNB-HPA, PEG4SH, and THA. Prior to enzymatic degradation, we evaluated the stiffness of 
these gels prior to and after TYR-treatment. As expected, hydrogels crosslinked with GelNB 
were not sensitive to TYR-triggered stiffening, as demonstrated by their relatively constant 
moduli (~1 kPa. Fig. 5A). On the other hand, the use of GelNB-HPA rendered the hydrogels 
sensitive to TYR-triggered on-demand stiffening (Fig. 5A). For example, 1 kU/mL of TYR 
treatment to gels crosslinked by 0.7 wt% THA led to significant increase of gel moduli from ~1 
kPa to 3.5 kPa. Next, soft gels (~1 kPa) or TYR-stiffened gels (~3.5 kPa) were treated with 
collagenase-1 (40 U/mL, Fig. 5B) or hyaluronidase (300 U/mL, Fig. 5C). In general, stiffened 
gels degraded slower due to higher crosslinking density contributed by the additional di-HPA 
linkages [33]. Different from collagenase-mediated degradation where all gels were degraded 
regardless of stiffness, limited hyaluronidase-mediated degradation was observed (~25% mass 
loss) in TYR-stiffened gels.  
Effect of matrix compositions on PDAC morphological changes           
 To study the influences of matrix compositions on PDAC cells, we evaluated proliferation 
and morphology of COLO-357 cells, a PDAC cell line with wild-type KRAS, in modularly 
crosslinked hydrogels, including: (1) GelNB with PEG4SH (Gel/PEG), (2) GelNB with THA 
(Gel/HA), (3) GelNB-HPA with PEG4SH (GelHPA/PEG), and (4) GelNB-HPA with THA 
(GelHPA/HA). Note that only gels with GelNB-HPA were susceptible to TYR-mediated dynamic 
stiffening. These gels were formulated such that they had similar initial shear moduli (i.e., 7 wt% 
GelNB or GelNB-HPA, 1.4 wt% PEG4SH, 0.7 wt% THA. G’ ~ 1 kPa). Live/dead staining images 
showed high cell viability after the initial cell encapsulation process and throughout the 14-day in 
vitro culture (Fig. 6A). Cells grew into spheroids or clusters in all gels but were visibly larger in 
Gel/PEG hydrogels (i.e., soft and HA-free). Cell proliferation was significantly inhibited (i.e., 
smaller spheroids) when the hydrogels were soft and contained HA (i.e., Gel/HA) or stiffened 
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but contained no HA (i.e., GelHPA/PEG). Interestingly, the morphology of the spheroids/clusters 
in GelHPA/HA gels became highly irregular (Fig. 6A, right column), an indication of increased cell 
motility. This could be attributed to higher cell proliferation and/or migration. F-actin staining 
images also revealed extensive spreading of PDAC cells encapsulated in GelHPA/HA gels (Fig. 
6B).  
 To quantify changes of spheroid sizes in matrices with different compositions, we analyzed 
spheroids size from live/dead stained images (Fig. 6C). The average diameter of spheroids was 
around 20 µm on day 2 in all gels (Fig. S1). Cells encapsulated in soft HA-free matrix (i.e., 
Gel/PEG) grew into relative large spheroids (~50 µm), whereas the size of cell spheroids in 
Gel/HA and GelHPA/PEG gels maintained at around 20-30 µm on day 14 (Fig. S1). As for PDAC 
cells encapsulated in GelHPA/HA gels, the spheroids appeared to have similar sizes as the other 
groups at early days (~20 µm from day 2 to day 7, Fig. 6A). However, due to the highly irregular 
cell morphology on day 14, we did not analyze cluster sizes in this condition (Fig. 6C).             
Analyses of PDAC-related mRNA expression  
 To gain insight into the influences of microenvironment changes on PDAC cells, we 
evaluated mRNA expression profiles using TaqMan® Array – Human Pancreatic 
Adenocarcinoma, which contained pre-deposited primer sets for 92 PDAC-associated and 4 
housekeeping genes. Cells were encapsulated in the four groups of hydrogels as described in 
Fig. 6, following by TYR incubation for 6 hours on day 2 and culturing for additional 12 days (14 
days in total). As described before, only gels containing HPA groups would be stiffened. mRNA 
expression levels were detected using quantitative real time PCR in TaqMan® Array with pre-
deposited primers. The expression levels were normalized to GAPDH (housekeeping gene), 
then to the respective gene in the control group (i.e., Gel/PEG gels). The expression levels of all 
mRNAs in this group were set as one-fold). mRNA expression levels in the remaining three 
groups (each with three biological repeats) were ranked from the highest to the lowest fold-
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changes and then plotted into heat maps (Fig. 7, Table S2, S3). Among the 92 PDAC-related 
mRNAs, 29, 24, and 48 were up-regulated by more than 2-fold for cells encapsulated in Gel/HA 
(i.e., soft and with HA), GelHPA/PEG (i.e., stiffened and HA-free), and GelHPA/HA (i.e., stiffened 
and HA-containing) gels, respectively. Furthermore, 52, 48 and 32 mRNAs were down-
regulated by more than 2-fold in respective gels. The much higher number of mRNA (i.e., 48) 
upregulated in the cells encapsulated in GelHPA/HA gels suggested a potential synergistic effect 
of HA and a stiffening matrix on PDAC cell progression.  
 We further examined the expression of genes that were only upregulated in cells 
encapsulated in stiffened gels (Fig. 8A), in HA-containing gels (Fig. 8B), as well as in stiffened 
and HA-containing gels (Fig. 8C). We found that the expression of MMP2 (encodes matrix 
metalloproteinase 2), TGF-β3, CCNB1 (encodes Cyclin B1), CCNE2 (encodes Cyclin E2), and 
E2F3 (encodes E2F transcription factor 3) were significantly upregulated in cells encapsulated 
in TYR-stiffened gels (Fig. 8A). We also identified mRNAs that were exclusively upregulated by 
the presence of HA regardless of matrix stiffness, including FIGF (encodes VEGF-D), ERBB2 
(encodes Erb-B2 Receptor Tyrosine Kinase 2), KRAS (encodes K-Ras), SRC (encodes Src), 
NOTCH1 (encodes Notch-1), BCL2L1 (encodes Bcl-2-Like Protein 1), ELK1 (encodes ETS 
Transcription Factor), STAT6 (encodes Signal Transducer and Activator of Transcription 6), 
MAP2K2 (encodes Mitogen-Activated Protein Kinase Kinase 2), and STAT5B (encodes Signal 
Transducer and Activator of Transcription 5B) (Fig. 8B). Finally, genes that were upregulated 
only in a stiffened and HA-containing matrix were RAC2 (encodes Small GTP Binding Protein 
Rac2), TGFβR1 (encodes TGFβ receptor 1), TGF-β2, TP53 (encodes Tumor suppressor P53), 
NFKB1 (encodes Nuclear Factor KB1), AKT1 (encodes serine-threonine protein kinase), RELB 
(encodes NF-KB Subunit), JAK3 (encodes Janus Kinase 3), CDKN2A (encodes Cyclin 
Dependent Kinase Inhibitor 2A), EGFR (encodes EGF receptor), RAC1 (encodes Small GTP 
Binding Protein Rac1), SOS1 (encodes SOS Ras/Rac Guanine Nucleotide Exchange Factor 1), 
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AKT2 (encodes AKT Serine/Threonine Kinase 2), and RHOA (encodes Ras Homolog Family 
Member A) (Fig. 8C).   
Evaluation of relationship between matrices properties and EMT induction 
 To understand if cell phenotypes observed in GelHPA/HA gels were a result of matrix-
induced EMT (Fig. 6A), we characterized the expression of epithelial and mesenchymal 
markers (Fig. 9A) using immunostaining and real-time PCR (Fig. 9B). Immunostaining results 
showed that when the HA-containing hydrogels were dynamically stiffened (i.e., GelHPA/HA), the 
expression of epithelial marker E-cadherin (E-cad) decreased drastically (Fig. 9A), whereas the 
expression of N-cadherin (N-cad, a mesenchymal marker) was visibly noticeable. On the other 
hand, qPCR results (Fig. 9B) revealed significantly lower level of E-Cad mRNA expression 
(CDH1, ~0.5-fold), as well as higher expression levels of mesenchymal markers, including N-
cad (CDH2, ~2-fold), SNAIL1 (~1.7-fold), vimentin (VIM, ~2.6-fold), and Sonic hedgehog (SHH, 
~2.3-fold). Importantly, tyrosinase alone did not cause the observed changes in EMT-related 
mRNA expressions (Fig. S2). Spreading cell phenotype and upregulation of mesenchymal cell 
markers in HA-containing/stiffened gels were also obtained using a second PDAC cell line, 
PANC-1 (Fig. S3). These results demonstrated that EMT was likely the cause of on cell 
spreading/invasion in the HA-containing gels that had been dynamically stiffened. 
Discussion 
 PDAC microenvironment is a complex network of cells, growth factors, and extracellular 
matrices whose compositions and properties change significantly as the tumor progresses (Fig. 
1). The dynamic changes in the TME pose significant challenges for in vitro cancer research 
and for testing the efficacy of anti-stromal therapeutics. Therefore ideal in vitro 3D cell culture 
platforms for cancer research should have modular and adaptable matrix compositions, as well 
as dynamically tunable matrix stiffness. Commercial matrices like Matrigel® can provide a 
convenient 3D culture model but do not have defined compositions and dynamically tunable 
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properties, making it difficult to study the impact of ECM on cancer cell behavior and fate. 
Alternatively, hydrogels crosslinked by gelatin (Gel) and hyaluronic acid (HA) are increasingly 
developed as 3D cell culture matrices owing to their protease degradability and bioactive 
sequences that are critical in promoting cell proliferation and migration. Besides complex 
features of ECM composition, accumulating evidence suggest that matrix mechanics is an 
indispensable parameter regulating cancer cell biology [44-46]. Numerous studies have utilized 
synthetic hydrogels with tunable stiffness to investigate cancer mechanotransduction. For 
example, our group has reported Gel/HA hydrogels formed by visible light initiated thiol-
norbornene photopolymerization to study the influence of hydrogel crosslinking and 
compositions on PDAC cell fate [32]. Our earlier efforts have demonstrated that matrix 
compositions influence the expression of some critical genes related to tumor progression, such 
as MMP-14, SHH [32], and vascular endothelial growth factors (VEGF) [30]. Moreover, PDAC 
cells grown in stiffer hydrogels were less susceptible to anti-tumor drugs [10], hence reinforcing 
the importance of developing an adaptable tumor-mimetic matrix for in vitro cancer research.  
 The hydrogels developed in the current study integrated modular thiol-norbornene 
crosslinking (Fig. 1D) [32, 36, 47] with the enzyme-triggered dynamic stiffening strategy (Fig. 
1E) that we reported previously [33]. The basic macromer used in this study was gelatin – 
denatured collagen with enhanced solubility. Native gelatin and modified gelatin macromers are 
widely used in tissue engineering and regenerative medicine applications owing to its bioactive 
peptide sequences that permit integrin-binding and protease-triggered degradation [48]. Our lab 
has also exploited modularly crosslinked gelatin-based hydrogels as 3D cell culture platforms 
[32, 49-51]. For example, we utilized GelNB as the main functional macromer to construct 
modular hydrogels for encapsulation and in vitro culture of hepatocellular carcinoma (HCC) [49] 
and PDAC cells [32]. We have also exploited tyrosinase-triggered di-tyrosine crosslinking for 
dynamically stiffening cell-laden hydrogels and for evaluating its effect on activation of 
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pancreatic stellate cells (PSCs), the major stroma cells in PDAC [33]. Built upon these work, we 
report here the use of modified gelatin (Fig. 1B, 2), THA (Fig. 1C), and bioinert macromer (e.g., 
PEG-tetra-thiol, PEG4SH) for constructing gels that were: (1) HA-free and soft (i.e., Gel/PEG 
gel), (2) HA-free and dynamically stiffened (i.e., GelHPA/PEG gel), (3) HA-containing and soft 
(i.e., Gel/HA gel), and (4) HA-containing and dynamically stiffened (i.e., GelHPA/HA gel). Note 
that gelatin was used in all gel formulations to provide basic cell adhesion and protease-
mediated degradation, whereas only gels composed of GelNB-HPA (i.e., GelHPA/PEG and 
GelHPA/HA) were susceptible to tyrosinase-triggered dynamic stiffening.  
 We fabricated cell-laden hydrogels with lower thiol-ene ratio but with higher content of 
GelNB-HPA to obtain gels that were initially soft (G’ < 1 kPa) but could be stiffened to 
physiologically-relevant modulus (G’ ~ 3 kPa. Fig. 3C), akin to what is observed in human 
PDAC samples and sufficient to induce cell phenotypic and mRNA expression changes [52-55]. 
As expected, tyrosinase-triggered HPA dimerization increased gel crosslinking and stiffness 
(Figs. 3C, 3D, 4, Fig. 5A). The degree of gel stiffening was highly tunable owing to the modular 
crosslinking nature of thiol-norbornene photopolymerization (Fig. 4). While soft hydrogels could 
be rapidly and completely degraded by collagenase (Fig. 5B) and hyaluronidase (Fig. 5C) 
within hours, tyrosinase-stiffened hydrogels were less sensitive to these enzymes. When treated 
with collagenase, degradation followed a surface erosion mechanism regardless of gel stiffness, 
as indicated by the almost linear mass loss profiles (Fig. 5B). This also applied to 
hyaluronidase-mediated degradation in soft gels (Fig. 5C). Exogenously added hyaluronidase, 
however, did not result in complete degradation of the stiffened gels (only ~ 25% mass loss 
(Fig. 5C). It was possible that the THA used in this study (from ESI·BIO) had high degree of 
thiolation, making it difficult for hyaluronidase to cleave HA backbone in a stiffened network. The 
susceptibility of HA-containing gels to hyaluronidase could be improved by using THA with lower 
degree of substitution. Nonetheless, all matrices were susceptible to degradation induced by 
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cell-secreted enzymes, a feature critical and necessary in cell-mediated matrix remodeling. It 
should be noted that these degradation studies were designed to inform the influence of 
tyrosinase-triggered gel stiffening on subsequent matrix degradation by relevant enzymes (i.e., 
collagenase and hyaluronidase). The fact that the stiffened gels were susceptible to 
exogenously added enzymes (especially collagenase) suggests that the encapsulated PDAC 
cells would still be able to degrade stiffened matrix locally, hence facilitating their proliferation, 
invasion, and migration.    
 The changes in cell morphology among different gel formulations and stiffening conditions 
indicated that 3D matrix composition exerts a profound impact on PDAC cell fate. Through 
modular control of gel compositions and dynamic stiffening, we show that the presence of HA in 
a soft gel (i.e., Gel/HA) or an HA-free but stiffened gel (i.e., GelHPA/PEG) hindered the growth of 
PDAC cells in 3D (Fig. 6), underscoring the complex relationship between cell proliferation, HA 
levels, and TME stiffness. On the other hand, smaller spheroids observed in the stiffened and 
HA-free gel could be a result of stress-induced signaling and physical restriction imposed by 
tighter network crosslinking after stiffening. We have observed a similar phenomenon in PDAC 
cells using hydrogels with higher but static stiffness [32]. However, the negative impact of 
network-immobilized HA on spheroid sizes was surprising since HA has been shown to induce 
PDAC cell proliferation in 2D culture [56]. The suppression of spheroid growth compared with 
that in soft and HA-free gel (i.e., Gel/PEG) could be due to the dependence of HA-mediated 
mitogenic signaling on matrix stiffness. Interestingly, when cells were grown in HA-containing 
and stiffened gels (i.e., GelHPA/HA), significant cell spreading was observed (Fig. 6A, 6B). This 
could be attributed to the upregulation of mRNAs implicated in the Ras/MAPK pathway, 
including RAC1, RAC2, RHOA, and RAF1 (Fig. 7B), and EMT-induced alterations. The 
upregulation of these mRNAs could lead to enhanced proliferation and to increased cell 
migration/invasion as observed in the stiffened and HA-containing hydrogel.  
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 We also identified mRNAs that were upregulated only when the cells were encapsulated in 
stiffened gels (Fig. 8A), in HA-containing gels (Fig. 8B), or in HA-containing and stiffened gel 
(Fig. 8C). We found that FIGF, ELK1, KRAS, SRC, and NOTCH1 were upregulated in cells 
grown in HA-containing gels, and that their expression was further upregulated when combined 
with gel stiffening. These findings are of crucial importance for several reasons. First, increased 
expression of KRAS and SRC is known to enhance tumorigenesis and metastasis [52, 57], and 
here we show for the first time that their expression is upregulated by key features found in the 
PDAC TME. Second, the upregulation of FIGF likely leads to increased levels of VEGF-D, which 
is known to promote lymph node metastasis in PDAC [58, 59]. Third, NOTCH1 encodes Notch 
1, whose activation correlates with increased drug resistance in PDAC [60-62].  
 Another interesting phenomenon is the elevated expression of MMPs, which are involved 
in ECM degradation and cancer cell invasion [63, 64]. We noted high levels of MMP7, the 
smallest member of the MMP family yet endowed with high proteolytic activity [65], in all 
experimental groups (compared to that in Gel/PEG hydrogel). On the other hand, MMP2 was 
only highly expressed in gels that were stiffened dynamically regardless of HA presence (Fig. 
8A). These findings suggest that our modular and dynamic hydrogels are ideal for future studies 
regarding the influence of matrix components on the expression and activity of MMPs or as an 
adaptable platform to test the efficacy of anti-MMP therapeutics. Furthermore, in a stiffened 
tumor-mimetic hydrogel, HA was found to upregulate mRNAs responsible for enhancing cancer 
cell survival and drug resistance (i.e., AKT1, AKT2, PIK2R1, PIK3R2, NFKNB1, and RELB. Fig. 
7, 8C).  
 Additional genes in the EGF and TGF-β pathways were significantly upregulated only in 
the setting of a stiffened and HA-containing microenvironment. These genes included TGFβR1, 
TGF-β2, and EGFR (Fig. 8C). Moreover, TGF-β3 was upregulated in the setting of a stiffened 
gel and further upregulated when combined with HA (Fig. 8A). These signaling events may 
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collaboratively lead to enhanced EMT in PDAC cells (Fig. 9). In addition, these observations 
underscore the fact that EGFR and TGF-β pathways are known to cross-talk in the context of 
upregulated Kras activity, thereby lead to autocrine dysregulation that promotes invasion and 
metastasis, as well as to aberrant paracrine actions that contribute to the desmosplasia in the 
TME and that impair cancer-directed immune mechanisms [66, 67]. While previous efforts have 
led to current understanding of soluble factors (e.g., growth factors, cytokines, soluble HA) on 
PDAC cell growth and EMT, the influence of 3D matrix compositions and time-dependent 
mechanics on PDAC cell fate remains elusive owing to the lack of a modular and adaptable 
biomimetic culture platform.  
 Although the GelHPA/HA gel system developed here only recapitulate certain aspects of the 
complex PDAC stroma, it nonetheless provides a highly relevant dynamic biomaterial platform 
for studying tumor cell-materials interactions in a reductionistic manner. Pancreatic cancer 
desmosplasia is undoubtedly highly complex. Precisely because of this complexity, it is 
important to establish model systems that allow for the reductionist dissection of specific 
components within the desmosplasia to understand how they contribute to pancreatic cancer 
pathobiology. In this contribution, we report the unique synergistic roles of HA and a stiffening 
matrix on PDAC cell behaviors, which has not been reported before. Accordingly, we document 
that HA and a stiffening matrix can lead to enhanced expression of KRAS and SRC, both of 
which are crucial contributors to pancreatic cancer aggressiveness, as well as increased VEGF-
D and Notch 1 expression which promote lymph node metastasis and chemoresistance, 
respectively. Collectively, these changes can lead to enhanced EMT in pancreatic cancer. The 
results presented here provide insight that could lead to novel therapeutic approaches based on 
targeting HA in combination of components of the above pathways. Built upon the current 
system, other stroma-relevant components (e.g., fibronectin, laminin) may be added in future 
studies to understand the crosstalk between these stroma components and matrix mechanics 
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on PDAC cell fate processes. Finally, the enzyme-responsive matrix stiffening approach is 
highly cytocompatible, controllable, and adaptable for creating cell-laden gels with spatial-
temporally regulated stiffness. Our on-going work is focused on generating biomimetic gels with 
stiffness gradient to evaluate durotatic cell migration and invasion in 3D.  
Conclusion 
 In conclusion, we have designed a biomimetic hydrogel capable of mimicking the diverse 
biochemical compositions and dynamic biophysical environment of pancreatic desmoplasia. The 
modular thiol-norbornene crosslinking of gelatin, HA, and PEG-based macromers decoupled the 
influence of HA and matrix stiffness on PDAC cell fate. Furthermore, the inclusion of HPA motif 
rendered the gels responsive to tyrosinase-triggered HPA dimerization and additional gel 
crosslinking. Through modular design, the hydrogels could be stiffened with high controllability. 
PDAC cells responded to the stiffening or HA-containing gel with limited cell proliferation. On the 
other hand, we confirmed that HA and matrix stiffening synergistically promoted invasive and 
matrix-induced EMT phenotype in PDAC cells. The desmoplasia-mimetic hydrogel developed 
here provides a diverse material platform for studying PDAC cell fate. Future work will focus on 
utilizing this versatile system for investigating cellular response to therapeutics under various 
matrix composition and mechanical properties. 
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Figure captions 
Figure 1. Enzyme-triggered on-demand stiffening of biomimetic hydrogels for in vitro 
cancer cell research. (A) Schematic of a tumor microenvironment with various matrix proteins 
and glycosaminoglycans (e.g., HA). Accumulation of these ECM leads to matrix stiffening and 
tumor progression. (B) Chemical structure of GelNB-HPA, (C) Chemical structure of THA. (D) 
Schematic of light and photoinitiator (LAP) induced thiol-norbornene crosslinking. (E) Schematic 
of tyrosinase-triggered di-HPA crosslinking and on-demand hydrogel stiffening. 
Figure 2. Characterizaiton of functionalized gelatin macromers. (A) 1NMR spectra of Gela-
tin, GelNB, and GelNB-HPA. (B-D) UV/Vis absorbance spectra of soluble GelNB and GelNB-
HPA (A), soluble GelNB treated with tyrosinase (TYR, 1 kU/mL) (C), and soluble GelNB-HPA 
treated with TYR (D). 
Figure 3. Characterization of thiol-norbornene gelation using functionalized gelation 
macromers. (A, B) Evolution of storage (G’) and loss (G’’) moduli of thiol-norbornene gelation 
using Gel/PEG (A) and GelHPA/PEG (B). GelNB or GelNB-HPA was added at 7 wt%, whereas 
PEG4SH was added at 1.4 wt% (R=0.5). (C) On-demand stiffening of Gel/PEG hydrogels via 
adding TYR at different concentrations (N=3, Mean ± SEM). (D) Photograph of tyrosinase-
stiffened hydrogels. 
Figure 4. Effect of macromer compositions on TYR-triggered on-demand gel stiffening. 
(A) Shear moduli of hydrogels formed by 7 wt% of gelatin macromer (GelNB and/or GelNB-
HPA) and 1.4 wt% PEG4SH. Gels were formed with different fractions of GelNB-HPA and 
GelNB. (B) Shear moduli of hydrogels formed by 3, 5, or 7 wt% of GelNB-HPA and with 0.7 wt% 
of PEG4SH, yielding gels with varied HPA contents but with similar initial modulus. (C) Shear 
moduli of hydrogels formed by 7 wt% of GelNB-HPA but with varied PEG4SH content to yield 
thiol/ene ratio of 0.3, 0.5, 0.7, 1. These gels contained the same HPA content but different initial 
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modulus. All hydrogels were treated with 1 kU/mL TYR from 0 – 6 hours (N=3, Mean ± SEM). 
Figure 5. Effect of tyrosinase-mediated gel stiffening on enzyme-mediated degradation. 
(A) Comparison of modulus changes in hydrogels modularly crosslinked by GelNB or GelNB-
HPA with PEG4SH or THA. Gel moduli were characterized prior to and after treating with 1 
kU/mL TYR for 6 hours (***p < 0.001). (B) Mass loss profiles of Gel/HA (soft) or GelHPA/HA 
(TYR-stiffened) hydrogels treated with collagenase (40 U/mL). (C) Mass loss profiles of Gel/HA 
(soft) or GelHPA/HA (TYR-stiffened) hydrogels treated with hyaluronidase (300 U/mL). Hydrogels 
in (B) and (C) were formed by 7% GelNB or GelNB-HPA with 0.7% THA (N=3, Mean ± SEM). 
Figure 6. Effect of matrix compositions on morphological changes of COLO-357 cells. (A) 
Representative confocal z-stack live/dead stained images of cells in Gel/PEG, Gel/HA, 
GelHPA/PEG, and GelHPA/HA gels. Gels were incubated with tyrosinase for 6 hours at day 2 and 
transferred to fresh media. (B) Confocal z-stack images of F-actin staining of encapsulated cells 
on day 14 post-encapsulation. Cell nuclei were counter-stained with DAPI. (C) Cell spheroid di-
ameters as a function of time and hydrogel formulations. Histograms were fitted with Gaussian 
distribution. 
Figure 7. Effect of matrix compositions on PDAC-related gene expression in COLO-357 
cells. Heat maps of Taqman® array analyses of gene expression in cells encapsulated in 
Gel/PEG (control group, data not shown in the figure as expression levels of all genes were set 
as one-fold), Gel/HA, GelHPA/PEG, and GelHPA/HA hydrogels. Gene expression levels (plotted in 
Log2 scale) were normalized to GAPDH within each group, then normalized to respective gene 
in Gel/PEG hydrogels. Each of the four gel formulations contained three biological replicates. 
Warm (red) colors showed high expression, whereas cold (blue) colors showed low expression. 
Figure 8. Identification of genes that were upregulated in COLO-357 cells encapsulated in 
specific gel formulations. (A) Stiffening gel regardless of HA presence, (B) HA-containing gel 
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regardless of gel stiffening, and (C) HA-containing and stiffened gel. Gene expression levels 
(plotted in Log2 scale) were normalized to GAPDH within each group, then normalized to 
respective gene in Gel/PEG hydrogels. Each of the four gel formulations contained three 
biological replicates. Warm (red) colors showed high expression, whereas cold (blue) colors 
showed low expression. 
Figure 9. Evaluation of selected epithelial and mesenchymal markers in COLO-357 cells 
grown in HA-containing and soft (i.e., Gel/HA) or in HA-containing and TYR-stiffened gels 
(i.e., GelHPA/HA). (A) Immunofluorescence staining of E-cadherin and N-cadherin. Cells were 
counterstained with DAPI. (B) mRNA expression levels of CDH1 (E-cadherin), CDH2 (N-
cadherin), SNAIL1, VIM (vimentin), and SHH (sonic hedgehog). All assays were conducted with 
samples collected at day 14. (Housekeeping gene: GAPDH. N=3, Mean ± SEM. *p<0.05, 
***p<0.001). 
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